Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Nova norma facilita o comércio de Excipientes Farmacêuticos entre os EUA e Brasil

A norma, baseada em consenso, incorpora vários requisitos regulatórios e industriais em uma única rigorosa norma para a fabricação de excipientes farmacêuticos.


News provided by

NSF International

Mar 12, 2015, 08:00 ET

Share this article

Share toX

Share this article

Share toX

PORTO ALEGRE, Brasil, 12 de março de 2015 /PRNewswire/ -- A NSF International, Organização de Saúde Pública Global, publicou a primeira Norma Nacional Norte Americana (American National Standard) para excipientes farmacêuticos – NSF/IPEC/ANSI 363: Good Manufacturing Practices (GMP) for Pharmaceutical Excipientes (Boas Práticas de Fabricação para Excipientes Farmacêuticos). A nova norma e programa de auditoria irão ajudar as empresas brasileiras a demonstrarem conformidade regulatória, segurança e qualidade dos seus excipientes para as empresas farmacêuticas no Brasil e em outros países.

Logo - http://photos.prnewswire.com/prnh/20110602/DC13023LOGO

A maioria das formulações farmacêuticas contêm entre 70 e 90% de excipientes que podem servir como mascaradores de sabor, fluidificantes, antioxidantes, auxiliares de fluidez, agentes ligantes ou para outros propósitos que facilitem o processo de fabricação e melhorem a estabilidade química dos produtos farmacêuticos. A globalização da indústria farmacêutica, combinada com regulamentações globais focadas na prevenção de falsificações e produtos adulterados, criou a necessidade de uma norma abrangente de controle e qualidade para excipientes. Por exemplo, o FDASIA (Food and Drug Administration Safety and Innovation Act), atualmente exige que os fabricantes verifiquem e documentem que a matéria prima usada no produto final estão de acordo com as referidas BPFs. A norma NSF/IPEC/ANSI 363 para as BPFs de excipientes farmacêuticos, oferece um conjunto de critérios abrangentes e harmonizados para o gerenciamento da qualidade do sistema usado na fabricação de excipientes farmacêuticos em todo o mundo.

A norma NSF/INPEC/ANSI 363 foi desenvolvida em parceria com o IPEC (International Pharmaceutical Excipients Council, Conselho Internacional de Excipientes Farmacêuticos), que considerou todas as informações que foram trazidas pelo comitê de especialistas em excipientes farmacêuticos, pela indústria e pela academia. A norma tem referencia a 14 guias regulatórios e normas da indústria para excipientes, incluindo regulamentações do FDA (USA Food and Drug Administration) Administração de Remédios e Alimentos dos EUA, do ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use), Conferencia Internacional sobre Harmonização de Requisitos Técnicos para Registro de Produtos Farmacêuticos para Consumo Humano, IPEC (International Pharmaceutical Excipients Council), Conselho Internacional de Excipientes e os guias para excipientes farmacêuticos do PQG (Pharmaceutical Quality Group), Grupo de Qualidade para Produtos Farmacêuticos.

"Através do desenvolvimento da NSF/IPEC/ANSI 363 e do resultado do seu programa de certificação, a NSF International está oferecendo aos fornecedores de excipientes uma maneira de demonstrar aos fabricantes de produtos farmacêuticos que seus produtos estão de acordo com os requisitos das BPFs, assegurando a qualidade da cadeia de suprimentos para produtos farmacêuticos, " disse Maxine Fritz, Vice Presidente de Pharma Biotech da NSF Health Sciences, uma divisão da NSF International.

"Empresas fabricantes de excipientes certificadas pela norma NSF/IPEC/ANSI 363 estão demonstrando que seus excipientes são fabricados de acordo com as BPF para o uso em produtos farmacêuticos, em que pode resultar em menor quantidade de auditorias por parte de clientes. Ambos os órgãos reguladores e indústrias são beneficiados com a economia de tempo e custos com uma norma harmonizada para BPF de excipientes como a NSF/IPEC/ANSI 363, " anunciou John Giannone, Presidente do IPEC – Américas.

Empresas de produtos farmacêuticos que compram excipientes certificados pela norma NSF/IPEC/ANSI 363 terão segurança adicional na qualidade dos excipientes e podem adquirir os relatórios de auditoria. Para mais informações sobre programa de auditoria em excipientes farmacêuticos da NSF International, entre em contato com Juliana Colete pelo telefone (11) 96789 4617 ou pelo email [email protected], ou então visite o site da NSF NSF International's website. Para a compra de uma cópia da norma NSF/IPEC/ANSI 363 visite a Book Store da NSF International.

Nota do editor: Para marcar uma entrevista com um perito em qualidade de excipientes, por favor, envie email para Juliana Colete, Gerente de Serviços a Clientes, pelo email [email protected] ou pelo telefone (11) 9678 4617.

A NSF International é uma organização global e independente de segurança em saúde pública que desenvolve normas, testa e certifica produtos para as indústrias de alimentos, água, suplementos dietéticos e de produtos de consumo de maneira a diminuir efeitos adversos à saúde e impactos ao meio ambiente (nsf.org). Fundada em 1944, a NSF está comprometida com a proteção e qualidade da saúde humana. A NSF International é um Centro Colaborador da OMS (Organização Mundial da Saúde) e da OPAS (Organização Pan-Americana da Saúde) na divisão Qualidade da Água e Alimentos e Ambientes fechados. A NSF Health Sciences Division, divisão de Ciências da Saúde da NSF, oferece treinamentos e consultoria educacional, auditorias, análises em GMP e GLP, Pesquisa e Desenvolvimento, guia regulador e conformidade corporativa para a área de biotecnologia farmacêutica, equipamentos médicos e serviços para a indústria de suplementos alimentares através do ciclo de vida dos produtos

FONTE NSF International

Related Links

http://www.nsf.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.